Journal article
Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography-Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors
Pancreas, Vol.49(8), pp.1033-1036
09/2020
DOI: 10.1097/MPA.0000000000001625
PMCID: PMC7447173
PMID: 32769854
Abstract
A prospective clinical trial evaluated the effect of Ga-DOTATOC positron emission tomography-computerized axial tomography (PET-CT) on change in management of patients with lung, pancreatic, and small bowel neuroendocrine tumors. The primary eligibility criterion was a histologically proven tumor with positive somatostatin receptor subtype 2A immunohistochemistry. The primary and secondary end points were change in patient management and safety.
Referring physicians completed questionnaires pre- and post-Ga-DOTATOC PET-CT, stating current and planned patient management, respectively, with tumor board adjudication of final management decisions. Change in management was categorized as follows: no change; minor change (additional imaging, supportive care); or major change (octreotide/lanreotide therapy, tumor biopsy, surgery, peptide receptor radiotherapy, chemotherapy, biological therapy, liver embolization).
A major change in management was recommended for 54 (47.37%) of 114 subjects and a minor change for 6 (5.26%) of 114 subjects, with no change for 54 (47.37%) of 114 subjects. Grade 1 adverse events were observed in 26 of 114 subjects (nausea, headache, back pain, diarrhea); one grade 2 (petechiae) and one grade 3 (abdominal pain) adverse event were observed. No grade 2 or 3 adverse events were related to study drug and none required intervention.
Imaging with Ga-DOTATOC PET-CT has a significant impact on management of patients with neuroendocrine tumors.
Details
- Title: Subtitle
- Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography-Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors
- Creators
- Silvia N Ghobrial - From the Departments of Pediatrics.Yusuf Menda - RadiologyGideon K Zamba - BiostatisticsSarah L Mott - BiostatisticsKristin Gaimari-Varner - Holden Comprehensive Cancer CenterDavid Dick - RadiologyJoseph Dillon - Departments of Medicine.James R Howe - SurgeryMichael Graham - RadiologyJohn Sunderland - RadiologyAndrew Bellizzi - University of IowaThomas M O'Dorisio - Departments of MedicineM Sue O'Dorisio - From the Departments of Pediatrics
- Resource Type
- Journal article
- Publication Details
- Pancreas, Vol.49(8), pp.1033-1036
- DOI
- 10.1097/MPA.0000000000001625
- PMID
- 32769854
- PMCID
- PMC7447173
- NLM abbreviation
- Pancreas
- ISSN
- 0885-3177
- eISSN
- 1536-4828
- Grant note
- R01 CA167632 / NCI NIH HHS P30 CA086862 / NCI NIH HHS P50 CA174521 / NCI NIH HHS
- Language
- English
- Date published
- 09/2020
- Academic Unit
- Radiology; Stead Family Department of Pediatrics; Pathology; Pharmaceutical Sciences and Experimental Therapeutics; Biostatistics; Surgery; Physics and Astronomy; Radiation Oncology; Fraternal Order of Eagles Diabetes Research Center; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984185279502771
Metrics
27 Record Views